11740 Results

People

  1. Vickers
    Vickers
  2. Offit
    Offit
  3. Robson
    Robson
  4. Horwitz
    Horwitz
  5. Kingham
    Kingham
  6. Panageas
    Panageas
  7. Breitbart
    Breitbart
  8. Halpern
    Halpern
  9. Jarnagin
    Jarnagin
  10. Nelson
    Nelson

Groups

  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)
  7. Psychiatry and Behavioral Sciences, Department of (2780)
  8. Biostatistics Service (2339)
  9. GSK Faculty (2008)
  10. Health Outcomes Research Group (1948)
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (7144)
  2. Meeting Abstract (3306)
  3. Book Section (330)
  4. Review (289)
  5. Editorial (253)
  6. Research Letter (116)
  7. Correspondence (111)
  8. Conference Paper (67)
  9. Guidelines (59)
  10. Miscellaneous (41)
  11. Book Whole (24)
Groups
  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)

More Groups

People
  1. Andrew Vickers (880)
  2. Kenneth Offit (788)
  3. Mark Robson (676)
  4. Steven Horwitz (645)
  5. T Peter Kingham (609)
  6. Katherine Panageas (512)

More People

Years
  1. 2025 (235)
  2. 2024 (722)
  3. 2023 (821)
  4. 2022 (828)
  5. 2021 (786)
  6. 2020 (738)

More Years

Publications
  1. Journal of Clinical Oncology (1246)
  2. Blood (374)
  3. Psycho-Oncology (347)
  4. Cancer (240)
  5. Cancer Research (234)
  6. Annals of Surgical Oncology (233)

More Publications

Publishers
  1. American Society of Clinical Oncology (1412)
  2. Elsevier Inc. (1128)
  3. Springer (1112)
  4. Elsevier Science, Inc. (816)
  5. Oxford University Press (753)
  6. Wiley Blackwell (614)

More Publishers

Results (11740)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of zone of origin in anterior-dominant prostatic tumors: Long-term biochemical recurrence-free survival in an anatomically well-annotated series
    Meeting Abstract

    Fine, S. W.; Al-Ahmadie, H.; Vertosick, E.; Sjoberg, D.; Vickers, A.; Chen, Y. B.; Gopalan, A.; Sirintrapun, S. J.; Tickoo, S.; Reuter, V.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Morphologic and molecular characterization of renal medullary carcinoma: A study of 18 cases
    Meeting Abstract

    Jia, L.; Carlo, M. I.; Khan, H.; Nanjangud, G. J.; Rana, S.; Hakimi, A. A.; Verma, A. K.; Al-Ahmadie, H.; Fine, S. W.; Gopalan, A.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • In colorectal carcinoma (CRC), true tumor cell staining for PD-L1 is uncommon and occurs in sporadic microsatellite-instable tumors with loss of MHC-I
    Meeting Abstract

    Liu, S.; Vyas, M.; Stadler, Z.; Weiser, M.; King, S.; Hechtman, J.; Vakiani, E.; Klimstra, D.; Shia, J.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Incidence and distribution of nodal metastases in sinonasal malignancy
    Meeting Abstract

    Alapati, S. K.; Unsal, A.; Cracchiolo, J.; Roman, B. R.; Lee, N.; Cohen, M.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced ejection fraction
    Meeting Abstract

    Hussain, Y.; Dang, C.; Steingart, R.; Liu, J.; Yu, A. F.
    Journal of the American College of Cardiology (2018)

    Fulltext@MSK | Save
  • Prospective evaluation of circulating biomarkers as predictors of cardiotoxicity in patients with HER2-positive breast cancer receiving anthracyclines and trastuzumab
    Meeting Abstract

    Yu, A. F.; Knezevic, A.; Moskowitz, C.; Dang, C.; Ramanathan, L.; Oeffinger, K.; Liu, J.; Steingart, R.
    Journal of the American College of Cardiology (2018)

    Fulltext@MSK | Save
  • Assessing implementation of tobacco treatment into cancer care: Feasibility, treatment fidelity, and acceptability
    Meeting Abstract

    Park, E.; Perez, G.; Regan, S.; Muzikansky, A.; Borderud, S.; Rabin, J.; Friedman, E.; Rigotti, N.; Ostroff, J.
    Implementation Science (2018)

    Fulltext@MSK | Save
  • The association between Polygenic Risk Scores and contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: Analyses in the CIMBA consortium
    Meeting Abstract

    Van den Broek, A.; Robson, M. E.; Vos, J.; Bernstein, J. L.; Offit, K.; Rookus, M. A.; Chenevix-Trench, G.; Easton, D. F.; Antoniou, A. C.; Schmidt, M. K.
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD
    Meeting Abstract

    Senkus-Konefka, E.; Domchek, S. M.; Im, S. A.; Xu, B.; Armstrong, A.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N.; Conte, P.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Evaluating mismatch repair deficiency in pancreatic adenocarcinoma: Challenges and recommendations
    Journal Article

    Hu, Z. I.; Shia, J.; Stadler, Z. K.; Varghese, A. M.; Capanu, M.; Salo-Mullen, E.; Lowery, M. A.; Diaz, L. A. Jr; Mandelker, D.; Yu, K. H.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save